Wrist-worn actigraphy in agitated late-stage dementia patients: A feasibility study on digital inclusion.
Ta-Wei Guu, Anna-Katharine Brem, Christopher P Albertyn...
https://pubmed.ncbi.nlm.nih.gov/38497216/Actively Recruiting
Led by China Medical University Hospital · Updated on 2026-02-11
20
Participants Needed
1
Research Sites
13 weeks
Total Duration
Taiwan is facing an aging population with increasing numbers of older adults living with Alzheimers disease. Many people with Alzheimers experience behavioral and psychological symptoms like agitation, sleep problems, or mood changes, which can lower their quality of life and increase stress for family caregivers. This research aims to evaluate how wearable devices might help monitor and manage these symptoms and caregiver burden in a rural Taiwanese setting. The study tests two wearable devices Geneactiv, a wristwatch that tracks daily activity and sleep for eight weeks, and Re-Timer, a light therapy eyewear emitting green light used for four weeks. Ten pairs of people with Alzheimers and their caregivers will participate over a twelve-week period. Researchers will assess the ease of device use, participant willingness to wear them, and whether the light therapy may improve sleep and mood. Participants will undergo assessments including questionnaires on sleep quality, behavioral symptoms, and caregiver burden, alongside data collected from the devices. Sleep quality will be measured from baseline to week 12, with actigraphy data collected throughout eight weeks. Feasibility and acceptability of using these devices will be monitored over the whole 12-week trial. This pilot study aims to guide future research on digital tools for dementia care in Taiwan.
CONDITIONS
Feasibility of Wearables in Dementia Care in Rural Taiwan
D
Dr Ta-Wei Guu Consultant psychiatrist, MD, PhD
Y
Yueh-Heng Chiang, RN, MS.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
China Medical University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants wear the Geneactiv wrist device for continuous monitoring of sleep and activity for eight weeks and use the Re-Timer light therapy glasses for four weeks to assess effects on sleep quality and behavioral symptoms.
1 baseline visit and multiple follow-up visits during the 12 weeks
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Ta-Wei Guu, Anna-Katharine Brem, Christopher P Albertyn...
https://pubmed.ncbi.nlm.nih.gov/38497216/Ta-Wei Guu, Dag Aarsland, Dominic Ffytche
https://pubmed.ncbi.nlm.nih.gov/35470491/China Medical University Hospital
Lead Sponsor